FDCS is now recognized to be a low-grade sarcoma of mesenchymal dendritic cell origin [2]. Earlier classification schemes had erroneously categorized it as a histiocytic or dendritic cell neoplasm of myeloid origin.
The term histiocytic neoplasm has historically been used to refer to tumors associated with monocyte/macrophage and dendritic cell phenotypes, including entities that are malignant (eg, FDCS, histiocytic sarcomas, interdigitating dendritic cell sarcoma, Langerhans cell sarcoma, indeterminate cell sarcomas) and benign (eg, Langerhans cell histiocytosis, Erdheim-Chester disease). FDCS is distinct because unlike the others, it is not of hematopoietic origin and its management more closely resembles that of other soft tissue sarcomas.
https://www.uptodate.com/contents/follicular-dendritic-cell-sarcoma
above. sisco thong
No comments:
Post a Comment